Cargando…

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes

OBJECTIVE: High cholesterol levels in circulating immune complexes (IC), surrogate markers of modified LDL, are associated with increased carotid intima-media thickness (IMT) and cardiovascular events in type 1 diabetes. Different modifications of LDL are involved in IC formation, but which of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes-Virella, Maria F., Hunt, Kelly J., Baker, Nathaniel L., Lachin, John, Nathan, David M., Virella, G.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028359/
https://www.ncbi.nlm.nih.gov/pubmed/20980456
http://dx.doi.org/10.2337/db10-0915
_version_ 1782197171180797952
author Lopes-Virella, Maria F.
Hunt, Kelly J.
Baker, Nathaniel L.
Lachin, John
Nathan, David M.
Virella, G.
author_facet Lopes-Virella, Maria F.
Hunt, Kelly J.
Baker, Nathaniel L.
Lachin, John
Nathan, David M.
Virella, G.
author_sort Lopes-Virella, Maria F.
collection PubMed
description OBJECTIVE: High cholesterol levels in circulating immune complexes (IC), surrogate markers of modified LDL, are associated with increased carotid intima-media thickness (IMT) and cardiovascular events in type 1 diabetes. Different modifications of LDL are involved in IC formation, but which of these are predictive of vascular events is not known. Therefore, we measured oxidized LDL (oxLDL), advanced glycation end products–modified LDL (AGE-LDL), and malondialdehyde-modified LDL (MDA-LDL) in IC and determined their relationship with increased carotid IMT and compared the strength of the association with that observed with conventional risk factors. RESEARCH DESIGN AND METHODS: Levels of oxLDL, AGE-LDL, and MDA-LDL were measured in circulating IC isolated from sera of 479 patients of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort, collected at baseline. Internal and common carotid IMT were measured 8 and 14 years later by DCCT/EDIC. RESULTS: OxLDL, AGE-LDL, and MDA-LDL levels in circulating IC were significantly correlated with diabetes duration, BMI, and lipid and blood pressure, but not with age. Multivariate logistic regression models indicated that individuals in the highest versus lowest quartile of oxLDL and AGE-LDL in IC had a 6.11-fold [confidence interval (CI) 2.51–14.8] and a 6.4-fold (CI 2.53–16.2) increase in the odds of having high carotid IMT, respectively, after adjusting for conventional risk factors. Parallel analyses resulted in odds ratios of 2.62 (CI 1.24, 5.55) for LDL-C, 1.45 (CI 0.69, 3.03) for diastolic blood pressure, and 2.33 (CI 1.09, 4.99) for A1C. CONCLUSIONS: OxLDL and AGE-LDL in circulating IC were significantly associated with progression and increased levels of carotid IMT in type 1 diabetes.
format Text
id pubmed-3028359
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-30283592012-02-01 Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes Lopes-Virella, Maria F. Hunt, Kelly J. Baker, Nathaniel L. Lachin, John Nathan, David M. Virella, G. Diabetes Complications OBJECTIVE: High cholesterol levels in circulating immune complexes (IC), surrogate markers of modified LDL, are associated with increased carotid intima-media thickness (IMT) and cardiovascular events in type 1 diabetes. Different modifications of LDL are involved in IC formation, but which of these are predictive of vascular events is not known. Therefore, we measured oxidized LDL (oxLDL), advanced glycation end products–modified LDL (AGE-LDL), and malondialdehyde-modified LDL (MDA-LDL) in IC and determined their relationship with increased carotid IMT and compared the strength of the association with that observed with conventional risk factors. RESEARCH DESIGN AND METHODS: Levels of oxLDL, AGE-LDL, and MDA-LDL were measured in circulating IC isolated from sera of 479 patients of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort, collected at baseline. Internal and common carotid IMT were measured 8 and 14 years later by DCCT/EDIC. RESULTS: OxLDL, AGE-LDL, and MDA-LDL levels in circulating IC were significantly correlated with diabetes duration, BMI, and lipid and blood pressure, but not with age. Multivariate logistic regression models indicated that individuals in the highest versus lowest quartile of oxLDL and AGE-LDL in IC had a 6.11-fold [confidence interval (CI) 2.51–14.8] and a 6.4-fold (CI 2.53–16.2) increase in the odds of having high carotid IMT, respectively, after adjusting for conventional risk factors. Parallel analyses resulted in odds ratios of 2.62 (CI 1.24, 5.55) for LDL-C, 1.45 (CI 0.69, 3.03) for diastolic blood pressure, and 2.33 (CI 1.09, 4.99) for A1C. CONCLUSIONS: OxLDL and AGE-LDL in circulating IC were significantly associated with progression and increased levels of carotid IMT in type 1 diabetes. American Diabetes Association 2011-02 2011-01-21 /pmc/articles/PMC3028359/ /pubmed/20980456 http://dx.doi.org/10.2337/db10-0915 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Lopes-Virella, Maria F.
Hunt, Kelly J.
Baker, Nathaniel L.
Lachin, John
Nathan, David M.
Virella, G.
Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title_full Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title_fullStr Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title_full_unstemmed Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title_short Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
title_sort levels of oxidized ldl and advanced glycation end products–modified ldl in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028359/
https://www.ncbi.nlm.nih.gov/pubmed/20980456
http://dx.doi.org/10.2337/db10-0915
work_keys_str_mv AT lopesvirellamariaf levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT huntkellyj levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT bakernathaniell levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT lachinjohn levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT nathandavidm levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT virellag levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes
AT levelsofoxidizedldlandadvancedglycationendproductsmodifiedldlincirculatingimmunecomplexesarestronglyassociatedwithincreasedlevelsofcarotidintimamediathicknessanditsprogressionintype1diabetes